HAP Trading’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $107K | Buy |
+29,500
| New | +$4.03M | 0.01% | 484 |
|
|
2023
Q1 | – | Sell |
-82,900
| Closed | -$26K | – | 1423 |
|
|
2022
Q4 | $26K | Buy |
82,900
+2,000
| +2% | +$258K | ﹤0.01% | 888 |
|
|
2022
Q3 | $33K | Buy |
80,900
+1,500
| +2% | +$186K | ﹤0.01% | 1088 |
|
|
2022
Q2 | $12K | Buy |
79,400
+700
| +0.9% | +$83.1K | ﹤0.01% | 1441 |
|
|
2022
Q1 | $71K | Sell |
78,700
-11,500
| -13% | -$1.5M | ﹤0.01% | 1143 |
|
|
2021
Q4 | $150K | Buy |
90,200
+5,500
| +6% | +$852K | ﹤0.01% | 1107 |
|
|
2021
Q3 | $453K | Buy |
84,700
+66,300
| +360% | +$11.2M | 0.01% | 712 |
|
|
2021
Q2 | $95K | Buy |
18,400
+5,000
| +37% | +$770K | ﹤0.01% | 1233 |
|
|
2021
Q1 | $236K | Sell |
13,400
-7,500
| -36% | -$1.19M | 0.01% | 707 |
|
|
2020
Q4 | $419K | Buy |
+20,900
| New | +$2.99M | 0.01% | 682 |
|
|
2020
Q3 | – | Sell |
-13,400
| Closed | -$122K | – | 1716 |
|
|
2020
Q2 | $122K | Buy |
+13,400
| New | +$1.71M | 0.01% | 807 |
|
|
2020
Q1 | – | Sell |
-110,900
| Closed | -$906K | – | 1346 |
|
|
2019
Q4 | $906K | Buy |
110,900
+7,700
| +7% | +$859K | 0.05% | 216 |
|
|
2019
Q3 | $87K | Sell |
103,200
-5,500
| -5% | -$576K | 0.01% | 636 |
|
|
2019
Q2 | $622K | Buy |
108,700
+55,400
| +104% | +$5.89M | 0.05% | 297 |
|
|
2019
Q1 | $408K | Buy |
+53,300
| New | +$5.85M | 0.04% | 321 |
|
|
2018
Q3 | – | Sell |
-376,500
| Closed | -$1.48M | – | 1080 |
|
|
2018
Q2 | $1.48M | Buy |
+376,500
| New | +$40.3M | 0.07% | 189 |
|
|
2018
Q1 | – | Sell |
-118,400
| Closed | -$328K | – | 1043 |
|
|
2017
Q4 | $328K | Buy |
118,400
+80,900
| +216% | +$8.65M | 0.01% | 438 |
|
|
2017
Q3 | $26K | Sell |
37,500
-56,700
| -60% | -$6.06M | ﹤0.01% | 725 |
|
|
2017
Q2 | $479K | Buy |
+94,200
| New | +$9.28M | 0.03% | 368 |
|
|
2016
Q1 | – | Sell |
-164,100
| Closed | -$134K | – | 906 |
|
|
2015
Q4 | $134K | Sell |
164,100
-4,800
| -3% | -$521K | 0.01% | 525 |
|
|
2015
Q3 | $45K | Buy |
+168,900
| New | +$20.3M | ﹤0.01% | 705 |
|
|
2015
Q1 | – | Sell |
-450,600
| Closed | -$6.72M | – | 1066 |
|
|
2014
Q4 | $6.72M | Sell |
450,600
-291,600
| -39% | -$28.3M | 0.25% | 83 |
|
|
2014
Q3 | $4.23M | Sell |
742,200
-515,700
| -41% | -$45.3M | 0.17% | 108 |
|
|
2014
Q2 | $7.57M | Sell |
1,257,900
-542,100
| -30% | -$42.7M | 0.28% | 70 |
|
|
2014
Q1 | $1.58M | Buy |
1,800,000
+1,230,000
| +216% | +$102M | 0.07% | 239 |
|
|
2013
Q4 | $1.65M | Buy |
570,000
+210,000
| +58% | +$14.9M | 0.05% | 300 |
|
|
2013
Q3 | $352K | Sell |
360,000
-427,500
| -54% | -$28M | 0.01% | 607 |
|
|
2013
Q2 | $344K | Buy |
+787,500
| New | +$45.5M | 0.01% | 576 |
|
Other funds holding IBB
CB
HAP Trading's IBB Position: Q1 2023 in Review
HAP Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 10,063 shares — an estimated $1.32M sold.
HAP Trading first reported a position in IBB in Q3 2013 and held it in 10 quarters. The position peaked at $14.9M in Q4 2014. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- HAP Trading reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
- HAP Trading sold 10,063 iShares Biotechnology ETF shares in Q1 2023, an estimated $1.32M.
- HAP Trading first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 10 quarters.
- HAP Trading's iShares Biotechnology ETF position peaked at $14.9M in Q4 2014.
- 867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.